Vous avez cherché: ht ht (Anglais - Maltais)

15000 euro ht
eur 15000 ht

ht-2 toxin;
tossina ht-2;

domestic overnig ­ ht
istituzzjo ­ nijiet mhux ifm domes ­ tika over ­ night

iternet ht − 2310
iternet ht − 2310

total against g ht c k ing)
total tal-bnedmin )

h1 receptor antagonists, 5-ht agonists
antagonisti tar-riċettur h1, agonisti 5-ht

overnig ­ ht other general governm ­ ent
gvern ġenerali oħra over ­ night

overnig ­ ht other financial interme ­ diaries
intermed ­ jarji finanz ­ jarji oħra

other partici ­ pating member states overnig ­ ht
stati membri parteċi ­ panti oħra stati membri parteċi ­ panti oħra stati membri parteċi ­ panti oħra stati membri parteċi ­ panti oħra over ­ night over ­ night

in specifying ht(),  is given in years.
fl-ispeċifikazzjoni ta’ ht(),  jingħata fi snin.

other partici ­ pating member states other partici ­ pating member states other partici ­ pating member states other partici ­ pating member states other partici ­ pating member states overnig ­ ht overnig ­ ht
stati membri parteċi ­ panti oħra stati membri parteċi ­ panti oħra stati membri parteċi ­ panti oħra stati membri parteċi ­ panti oħra stati membri parteċi ­ panti oħra over ­ night over ­ night

orfadin is used to treat hereditary tyrosinaemia type 1 (ht-1).
orfadin jintuża għall-kura tat-tirosinemija ereditarja tat-tip 1 (ht-1).

in patients with ht-1, these intermediates are converted to the toxic metabolites succinylacetone and succinylacetoacetate.
f’pazjenti b’ht-1, dawn l-intermedji jinbidlu għal metaboliti tossiċi succinylacetone u succinylacetoacetate.

where: rt ht= remuneration to be paid on holdings of required reserves for the maintenance period t;
= ir-remunerazzjoni li ghandha tigi mhallsa fuq il-kumpanijja tar-riservi mitluba ghall-perjodu ta » manutenzjoni t;

epoetin delta is produced in human cells (ht-1080) by gene-activation technology.
epoetin delta hu prodott fiċ-ċelluli tal-bniedem (ht-1080) bit-teknoloġija ta’ l-attivazzjoni tal-ġeni.